Adenosine conversion of supraventricular tachycardia associated with high-dose epinephrine therapy for cardiac arrest

Prehosp Disaster Med. 1999 Apr-Jun;14(2):97-9.

Abstract

Adenosine has received wide acceptance as the drug of choice for initial treatment of supraventricular tachycardias (SVT), and as a diagnostic adjunct in hemodynamically stable, wide-complex tachycardias. This report describes the successful use of adenosine for the treatment of SVT occurring after successful initial resuscitation from ventricular fibrillation, in which a high dose of the epinephrine protocol was used.

Publication types

  • Case Reports

MeSH terms

  • Adenosine / pharmacology
  • Adenosine / therapeutic use*
  • Aged
  • Aged, 80 and over
  • Anti-Arrhythmia Agents / pharmacology
  • Anti-Arrhythmia Agents / therapeutic use*
  • Cardiopulmonary Resuscitation / adverse effects*
  • Cardiopulmonary Resuscitation / methods*
  • Electric Countershock
  • Electrocardiography
  • Emergency Medical Services
  • Epinephrine / adverse effects*
  • Heart Arrest / drug therapy*
  • Humans
  • Infusions, Intravenous
  • Male
  • Tachycardia, Supraventricular / chemically induced*
  • Tachycardia, Supraventricular / diagnosis
  • Tachycardia, Supraventricular / drug therapy*
  • Vasoconstrictor Agents / adverse effects*
  • Ventricular Fibrillation / diagnosis
  • Ventricular Fibrillation / drug therapy*

Substances

  • Anti-Arrhythmia Agents
  • Vasoconstrictor Agents
  • Adenosine
  • Epinephrine